The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of sequencing weekly paclitaxel (T) and dose-dense doxorubicin/cyclophosphamide (DDAC) on tolerability and relative dose intensity (RDI) in breast cancer (BC) patients (pts) receiving neoadjuvant chemotherapy (NAC).
 
Nicholas Martin LeCroy
No Relationships to Disclose
 
Irene Borrero
No Relationships to Disclose
 
Dina Bernie Dumercy
No Relationships to Disclose
 
Evelio Velis
No Relationships to Disclose
 
Alejandra T. Perez
No Relationships to Disclose
 
Michel Velez
No Relationships to Disclose
 
Aruna Mani
No Relationships to Disclose
 
Aurelio Bartolome Castrellon
No Relationships to Disclose
 
Carla Hawkins Locke
No Relationships to Disclose
 
Cynthia Frankel
No Relationships to Disclose
 
Candice Sareli
No Relationships to Disclose
 
Carmen Julia Calfa
No Relationships to Disclose